Nonlinear association of HbA1c/HDL-C ratio with heart failure in adults: a large cross-sectional study
Frontiers in Cardiovascular Medicine · 03.06.2026 · 13
DOI: 10.3389/fcvm.2026.1844807 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Miao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Heart failure (HF) remains a leading cause of morbidity and mortality worldwide. The HbA1c/HDL-C ratio, a novel composite biomarker reflecting glycemic control and lipid metabolism, may be associated with HF risk, but its specific relationship remains underexplored. This study aimed to investigate the association between the HbA1c/HDL-C ratio and HF.
Methods
We utilized samples from two sources: 1,360 inpatients from a cardiology department in 2020 and 101,316 participants from the National Health and Nutrition Examination Survey ( N HANES) 1999–2018. Multivariate logistic regression, subgroup analyses, restricted cubic spline (RCS) regression, and receiver-operating characteristic (ROC) curve analysis were employed to examine the relationship.
Results
In an analysis of the NHANES sample including 48,922 participants, 1,598 individuals were identified as having HF, corresponding to a prevalence of 3.27%. In a separate clinical sample of 584 participants, 132 had HF, yielding an overall prevalence of 22.60%. After full adjustment, the HbA1c/HDL-C ratio demonstrated a consistent positive association with HF risk in both the NHANES sample (OR =1.07, 95% CI: 1.01–1.14; P = 0.033) and the clinical sample (OR = 1.15, 95% CI: 1.01–1.30; P = 0.029). Furthermore, a nonlinear relationship between the HbA1c/HDL-C ratio and HF risk was observed in both populations, with an inflection point identified at 6.21. Below this threshold (HbA1c/HDL-C < 6.21), the adjusted OR was 1.22 (95% CI: 1.09–1.37; P = 0.001) in the NHANES sample and 1.65 (95% CI: 1.20–2.28; P = 0.002) in the clinical sample. Above the inflection point (HbA1c/HDL-C ≥ 6.21), the association attenuated and became statistically nonsignificant. The ROC curve analysis also confirmed that the HbA1c/HDL-C ratio combination had more robust predictive power for heart failure than HbA1c and HDL-C alone ( P < 0.05).
Conclusion
This study found a nonlinear positive association between the HbA1c/HDL-C ratio and the risk of HF, identifying key threshold values.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Cardiology, Changdu People's Hospital of Xizang, Xizang, China.
- Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, China.
Zitieren
APA
Li, M., Hu, M., Ma, X., Ciren, Z., Cideng, D., Qu, G., & Silang, Y. (2026). Nonlinear association of HbA1c/HDL-C ratio with heart failure in adults: a large cross-sectional study. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1844807
Vancouver
Li M, Hu M, Ma X, Ciren Z, Cideng D, Qu G, et al. Nonlinear association of HbA1c/HDL-C ratio with heart failure in adults: a large cross-sectional study. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1844807
BibTeX
@article{Li2026,
author = {Li, Miao and Hu, Mei and Ma, Xujue and Ciren, Zhuoga and Cideng, Dengzhu and Qu, Guangsu and Silang, Yangcuo},
title = {Nonlinear association of HbA1c/HDL-C ratio with heart failure in adults: a large cross-sectional study},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1844807}
}
EUVIMED